Integrating genomic features for non-invasive early lung cancer detectionJacob J. Chabon, Maximilian Diehn, Monica Nesselbush et al.|Nature|2020Cited by 689
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J. Chabon, Maximilian Diehn|Nature Communications|2016Cited by 657
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancerEverett J. Moding, Maximilian Diehn, Yufei Liu et al.|Nature Cancer|2020Cited by 369
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y. Nabet, Maximilian Diehn, Mohammad Shahrokh Esfahani et al.|Cell|2020Cited by 360
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNAJonathan C. Dudley, Maximilian Diehn, Joseph G. Schroers‐Martin et al.|Cancer Discovery|2018Cited by 238